MENTHOL
本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。
全球证据概览
所解析的身份在 13 个已索引市场数据集中的 3 个有匹配的监管证据:2 条国家记录和 1 条欧盟附件记录。下方列出每项结果和证据缺口。
已解析的物质身份
5 个匹配或报告的名称
全部 13 个市场的监管证据
打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。
滑动或横向滚动以查看数据集覆盖范围和后续操作。
| 市场 | 结果 | 记录 | 数据集 | 含义 / 后续操作 |
|---|---|---|---|---|
| European Union EU | 限用 | 1打开记录 1 | Complete annex dataset Regulation (EC) 1223/2009 consolidated to 1 May 2026 | 请查看每条关联记录及其确切条件。 |
| Great Britain GB | 未找到匹配项 | 0 | Complete consolidated annex dataset GB retained Regulation 1223/2009 schedules, effective 15 August 2026 | No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework. |
| Canada CA | 未找到匹配项 | 0 | Complete Hotlist snapshot Health Canada Cosmetic Ingredient Hotlist, 13 August 2025 | The Hotlist is an administrative compliance tool, not an exhaustive safety approval list. |
| New Zealand NZ | 未找到匹配项 | 0 | Complete schedules dataset Cosmetic Products Group Standard schedules effective 1 January 2026 | The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative. |
| ASEAN ASEAN | 未找到匹配项 | 0 | Complete regional annex dataset ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026 | Regional annex coverage does not replace member-state implementation dates, notifications or national deviations. |
| China CN | 未找到匹配项 | 0 | Complete prohibited catalogues plus official-source workflow NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025 | IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately. |
| Japan JP | 未找到匹配项 | 0 | Complete Standards appendices dataset MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot | The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion. |
| South Korea KR | 未找到匹配项 | 0 | Complete current appendix dataset MFDS Notice 2026-19, effective 18 March 2026 | Korean source wording is canonical and other positive lists/notices may still apply to the formulation. |
| United States US | 未找到匹配项 | 0 | Complete enumerated federal ingredient rules eCFR Title 21 issue date 27 August 2026 | FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety. |
| Australia AU | 未找到匹配项 | 0 | Complete cosmetic-relevant Poisons Standard subset plus official workflow Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026 | An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction. |
| Brazil BR | 未找到匹配项 | 0 | Complete prohibited dataset plus current restricted-list workflow ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026 | RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026. |
| India IN | Restricted | 1打开记录 1 | Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4 Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022) | 请查看每条关联记录及其确切条件。 |
| Saudi Arabia SA | Restricted | 1打开记录 1 | Complete official list index SFDA live prohibited/restricted lists, snapshot 30 August 2026 | 请查看每条关联记录及其确切条件。 |
匹配的市场记录和条件
India
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)Saudi Arabia
SFDA live prohibited/restricted lists, snapshot 30 August 2026附件 II–VI 的精确证据
Menthol
限制: The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.
化学身份与性质

Menthol
P-menthan-3-ol is any secondary alcohol that is one of the eight possible diastereoisomers of 5-methyl-2-(propan-2-yl)cyclohexan-1-ol. It has a role as a volatile oil component. It is a p-menthane monoterpenoid and a secondary alcohol. — ChEBI
- IUPAC 名称
- 5-methyl-2-propan-2-ylcyclohexan-1-ol
- 分子式
- C10H20O
- 分子量
- 156.26 g/mol
- 精确质量
- 156.151415257 Da
- XLogP3
- 3.0
- 拓扑极性表面积
- 20.2 Ų
- 氢键供体
- 1
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 0
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:25187
- ChEMBL:CHEMBL256087
- EPA DTXSID:DTXSID8029650
- PubMed:22953891
- PubMed:22944434
- PubMed:22878261
- PubMed:22649749
- PubMed:22064618
- PubMed:21964764
- PubMed:21754537
- PubMed:21754488
- PubMed:21720039
- PubMed:21665944
- PubMed:21624153
- PubMed:21615034
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

(+)-Menthol
(+)-menthol is a p-menthan-3-ol which has (1S,2R,5S)-stereochemistry. In contrast to ()-menthol, the (+)-enantiomer occurs only rarely in nature. It is an enantiomer of a (-)-menthol. — ChEBI
- IUPAC 名称
- (1S,2R,5S)-5-methyl-2-propan-2-ylcyclohexan-1-ol
- 分子式
- C10H20O
- 分子量
- 156.26 g/mol
- 精确质量
- 156.151415257 Da
- XLogP3
- 3.0
- 拓扑极性表面积
- 20.2 Ų
- 氢键供体
- 1
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 3
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:76306
- ChEMBL:CHEMBL2106989
- EPA DTXSID:DTXSID8029733
- PubMed:14757700
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

(-)-Menthol
(-)-menthol is a p-menthan-3-ol which has (1R,2S,5R)-stereochemistry. It is the most common naturally occurring enantiomer. It has a role as an antitussive, an antispasmodic drug and an antipruritic drug. It is an enantiomer of a (+)-menthol. — ChEBI
- IUPAC 名称
- (1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol
- 分子式
- C10H20O
- 分子量
- 156.26 g/mol
- 精确质量
- 156.151415257 Da
- XLogP3
- 3.0
- 拓扑极性表面积
- 20.2 Ų
- 氢键供体
- 1
- 氢键受体
- 1
- 共价单元
- 1
- 已定义的立体中心
- 3
又称
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:15409
- ChEMBL:CHEMBL470670
- EPA DTXSID:DTXSID1020805
- EPA DTXSID:DTXSID1022180
- PubMed:23449869
- PubMed:23079223
- PubMed:23029512
- PubMed:23025381
- PubMed:23012335
- PubMed:23012334
- PubMed:23009608
- PubMed:23001121
- PubMed:23001015
- PubMed:22994173
- PubMed:22992809
- PubMed:22982120
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与范围
导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。
打开官方决定